Anti-GCNT3 monoclonal antibody

Pre-made anti-GCNT3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GCNT3/GCNT3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0893-Ab-1/ GM-Tg-hg-IP0893-Ab-2Anti-Human GCNT3 monoclonal antibodyHuman
GM-Tg-rg-IP0893-Ab-1/ GM-Tg-rg-IP0893-Ab-2Anti-Rat GCNT3 monoclonal antibodyRat
GM-Tg-mg-IP0893-Ab-1/ GM-Tg-mg-IP0893-Ab-2Anti-Mouse GCNT3 monoclonal antibodyMouse
GM-Tg-cynog-IP0893-Ab-1/ GM-Tg-cynog-IP0893-Ab-2Anti-Cynomolgus/ Rhesus macaque GCNT3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0893-Ab-1/ GM-Tg-felg-IP0893-Ab-2Anti-Feline GCNT3 monoclonal antibodyFeline
GM-Tg-cang-IP0893-Ab-1/ GM-Tg-cang-IP0893-Ab-2Anti-Canine GCNT3 monoclonal antibodyCanine
GM-Tg-bovg-IP0893-Ab-1/ GM-Tg-bovg-IP0893-Ab-2Anti-Bovine GCNT3 monoclonal antibodyBovine
GM-Tg-equg-IP0893-Ab-1/ GM-Tg-equg-IP0893-Ab-2Anti-Equine GCNT3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0893-Ab-1/ GM-Tg-hg-IP0893-Ab-2; GM-Tg-rg-IP0893-Ab-1/ GM-Tg-rg-IP0893-Ab-2;
GM-Tg-mg-IP0893-Ab-1/ GM-Tg-mg-IP0893-Ab-2; GM-Tg-cynog-IP0893-Ab-1/ GM-Tg-cynog-IP0893-Ab-2;
GM-Tg-felg-IP0893-Ab-1/ GM-Tg-felg-IP0893-Ab-2; GM-Tg-cang-IP0893-Ab-1/ GM-Tg-cang-IP0893-Ab-2;
GM-Tg-bovg-IP0893-Ab-1/ GM-Tg-bovg-IP0893-Ab-2; GM-Tg-equg-IP0893-Ab-1/ GM-Tg-equg-IP0893-Ab-2
Products NameAnti-GCNT3 monoclonal antibody
Formatmab
Target NameGCNT3
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GCNT3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0893-Ag-1Recombinant multi-species GCNT3/ C2/4GnT/ C24GNT protein


    Target information

    Target IDGM-IP0893
    Target NameGCNT3
    Gene ID9245,72077,286976,702754,487578,101101139,404167,100068109
    Gene Symbol and Synonyms2010013H22Rik,2210021I22Rik,2210401J11Rik,beta-16-N-acetylglucosaminyltransferase,C2/4GnT,C24GNT,C2GNT2,C2GN™,dI/C2/C4GnT,GCNT3,GN™
    Uniprot AccessionO95395,Q8CH87,Q7YQE1
    Uniprot Entry NameGCNT3_HUMAN,GCNT3_RAT,GCNT3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000140297
    Target ClassificationN/A

    The target: GCNT3, gene name: GCNT3, also named as C2/4GnT, C24GNT, C2GNT2, C2GN™, GN™. This gene encodes a member of the N-acetylglucosaminyltransferase family. The encoded protein is a beta-6-N-acetylglucosamine-transferase that catalyzes the formation of core 2 and core 4 O-glycans on mucin-type glycoproteins.[provided by RefSeq, Apr 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.